oncology

Showing 15 posts of 328 posts found.

Merck image

PD-1 cancer race heats up as Merck takes lead

July 2, 2014
Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab

Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …

Doctors who miss cancer to be named and shamed

July 1, 2014
Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology

In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …

ASCO image

Value tops the agenda at ASCO cancer conference

June 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology

The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …

Novartis emphasises pharma growth

June 19, 2014
Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory

Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …

Bruno image

Novartis hires Merck president to lead oncology

June 3, 2014
Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology

Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology.  The role was …

GSK signs Adaptimmune deal

June 3, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology

GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …

BMS image

BMS signs cancer deal

May 28, 2014
Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

roche_logo_shadow_7

Roche gets oncology boost with cancer vaccine

May 16, 2014
Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology

Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …

Medimmune image

MedImmune signs Incyte oncology deal

May 15, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology

MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …

gsk image

Mekinist shown green light by CHMP

April 28, 2014
Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib

GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …

Sarah Edwards image

Breaking into the oncology market

March 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Cancer, NSCLC, edwards, gilotrif, oncology

In many ways, the US approval of Boehringer’s Gilotrif for patients with late-stage non-small cell lung cancer (NSCLC) last year …

Cobra biologics image

Cobra agrees oncology deal with BioCancell

March 4, 2014
Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology

Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …

Abbvie image

AbbVie expands into Singapore

February 10, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology

AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …

Abbvie image

AbbVie advances oncology drug

January 21, 2014
Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer.  This …

The Gateway to Local Adoption Series

Latest content